filmov
tv
The Rationale for FOLFOX and Bevacizumab in mCRC
Показать описание
Wells Messersmith, MD, describes the rationale for using FOLFOX/bevacizumab as a second-line therapy in a patient with metastatic colorectal cancer and the rationale for continuing bevacizumab beyond progression.
0:05:02
The Rationale for FOLFOX and Bevacizumab in mCRC
0:13:20
GI chemotherapy education - Folfox
0:03:00
FOxTROT: neoadjuvant FOLFOX chemotherapy in colorectal cancer
0:00:06
side effects I’m experiencing of cycle 1 day 3 on folfox for colorectal cancer #chemotherapy #chemos...
0:03:49
mCRC: Combination Therapy and Testing
0:11:15
Debate: Borderline resectable liver metastasis in RAS WT CRC? - FOLFOX (or FOLFOXIRI)/Bev
0:03:53
Side Effects of Chemotherapy Options in Colorectal Cancer
0:06:19
Colorectal Cancer: FOLFOX versus FOLFIRI in the MAVERICC Trial
0:06:32
Panitumumab triplet therapy in colorectal cancer
0:09:07
TRIBE-2: FOLFOX or FOLFIRI With Bevacizumab in mCRC
0:05:42
mCRC: Considerations for Localized Therapy and Maintenance
0:00:18
How Chemotherapy Works 😱
0:01:11
Dr. Kopetz on the Rationale for the BEACON CRC Study in BRAF V600E-Mutant mCRC
0:06:37
Molecular Testing and First-Line Therapy in mCRC
0:10:02
PANDA: Combining panitumumab with FOLFOX or 5FU in elderly patients with RAS-BRAF WT metastatic ...
0:00:58
COLON CANCER MAY NEED HEMOCOLECTOMY ...ANTI VEGF THERAPY and FOLFOX AND FOLFIRI OR CAPE OX REGIMEN.
0:00:32
DKN-01 with bevacizumab and chemotherapy in advanced CRC
0:10:03
Guidelines for Metastatic Frontline Therapy in GEC
0:00:44
A step by step guide to chemoport | Dr. Deepak Jha
0:09:13
12 Things NO ONE Tells You About CHEMO (DON’T MISS THIS)
0:04:07
Postoperative Chemotherapy for Advanced Rectal Cancer
0:01:17
Dr. Long on the Rationale for the Phase 3 COMBI-i Trial in BRAF V600–Mutant Melanoma
0:04:44
Folfox Chemo Cycle 2 for Stage 4 Cancer | The Big C in Me
0:04:25
FIRE-4.5: FOLFOXIRI plus either bevacizumab or cetuximab in mCRC
Комментарии